« All News

IJID Special Issue: Dengue Fever in India

With dengue named as one of the top 10 threats to global health in 2019 that need prioritizing by the World Health Organization, concerted action by the global community is urgently needed to reduce dengue deaths and disease. India is often described as the epicenter of dengue and has pioneered research to improve health outcomes. The International Journal of Infectious Diseases (IJID) is proud to bring together scientists and public health specialists working on dengue in India and provide a platform for dissemination of current dengue research and control activities that can bring about a paradigm shift in global dengue control.

In this Special Issue, titled ‘Dengue Fever in India’ published in July 2019, the IJID highlights a concerted national and international effort under the leadership of the Indo-US Vaccine Action Program and the Indian government, to establish sustainable surveillance systems in India, improve diagnostics, establish innovative vector control, and develop novel dengue vaccines. These efforts can bring about a paradigm shift in global dengue control.

Read More

Archives

International Society for Infectious
Diseases

9 Babcock St, Unit 3 Brookline, MA
02446 USA

617-277-0551
[email protected]
Types
International Society for Infectious Diseases
867 Boylston Street, 5th Floor #1985
Boston, MA 02116
USA


Phone 1+617-925-5272
Fax 1+617-865-7031

[email protected]

Our Mission
At the International Society for Infectious Diseases (ISID), our mission is to support health professionals, non-government organizations, and governments around the world in their work to prevent, investigate, and manage infectious disease outbreaks when they occur.

©2024 International Society for Infectious Diseases

Nicolette du Plessis

Prof Nicolette du Plessis, a registered Paediatric Infectious Diseases Specialist, is an Associate Professor and Head of the Paediatric Infectious Diseases Division of the Department of Paediatrics at the University of Pretoria and Kalafong Hospital. Her interests and research in the field of Paediatric Infectious Diseases lead to her PhD, which focused on early HIV diagnosis and treatment. Other interests include Immunology, Allergology, Travel medicine, Tuberculosis, immunization and vaccine-preventable diseases, outbreak investigation, and Antibiotic stewardship. Her recent research projects focus on paediatric Covid 19 and HIV. She is currently the president of FIDSSA and she serves on numerous advisory boards both locally and nationally.

Nicolette du Plessis

Prof Nicolette du Plessis, a registered Paediatric Infectious Diseases Specialist, is an Associate Professor and Head of the Paediatric Infectious Diseases Division of the Department of Paediatrics at the University of Pretoria and Kalafong Hospital. Her interests and research in the field of Paediatric Infectious Diseases lead to her PhD, which focused on early HIV diagnosis and treatment. Other interests include Immunology, Allergology, Travel medicine, Tuberculosis, immunization and vaccine-preventable diseases, outbreak investigation, and Antibiotic stewardship. Her recent research projects focus on paediatric Covid 19 and HIV. She is currently the president of FIDSSA and she serves on numerous advisory boards both locally and nationally.

Scott Dowell

Scott F. Dowell, a pediatric infectious disease specialist by training, serves as Senior Advisor, Global Health Emergency Corps at the World Health Organization. Prior to that he spent a decade overseeing disease surveillance work at the Bill and Melinda Gates Foundation and led its $2 billion response to the Covid-19 pandemic, contributing in a small way to saving some 19 million lives. Dr. Dowell spent 20 years at the U.S. Centers for Disease Control and Prevention (CDC), where he studied viral and bacterial pneumonia, and responded to outbreaks of Ebola and other pathogens. He established and directed the International Emerging Infections Program in Thailand, a collaboration that received accolades from both the Thai and U.S. governments for its prominent role in responding to the SARS crisis, and for its leadership in defining the response to avian influenza A (H5N1) in Southeast Asia. He led CDC’s response to the earthquake and cholera epidemic in Haiti, helping to rebuild the public health infrastructure and contributing to the saving of an estimated 7,000 lives. Dr. Dowell served as the Director of the World Health Organization Collaborating Center for International Health Regulations and the Division of Global Disease Detection and Emergency Response and established the agency’s Global Health Security Agenda. In 2014, he retired from the US Public Health Service at the rank of Rear Admiral and Assistant Surgeon General. Dr. Dowell has co-authored more than 190 publications, holds an Uber rating of 4.89, and has a special interest in targeted reductions of childhood mortality.

Shui Shan Lee

Dr. Lee is a clinician and specialist in internal medicine, immunopathology, and public health. He joined The Chinese University of Hong Kong in 2005 and is currently a Professor and Deputy Director of the University’s S.H. Ho Research Centre for Infectious Diseases. Between 1991 and 2005, Dr. Lee headed the Hong Kong Government’s AIDS programme, directing the territory’s HIV prevention, control and treatment services. He is the founding president of the Hong Kong Society for HIV Medicine and was chairman of the government’s scientific committee on AIDS and STIs between 2016 and 2022. Since 2022, he’s been serving as the Editor-in-Chief of the International Journal of Infection Diseases. Dr. Lee has, on various occasions, served as a consultant to national and international organisations in the assessment of HIV situations, programme evaluations, and advice on harm reduction development. His primary areas of research interest include a biomedical approach to HIV/STI prevention, infectious disease epidemiology, and emerging infectious diseases. Dr. Lee has authored over 300 peer-reviewed articles and 40 book chapters and is the editor of the HIV Manual in Hong Kong.

Sean Wasserman

Sean Wasserman is a clinical academic with training in Internal Medicine and Infectious Diseases. He has an active programme of clinical research on treatment optimisation for tuberculosis, HIV, and associated opportunistic infections. His research aims to address clinically important questions through translational studies, emphasizing reducing the infection burden in underserved populations. Sean has spent most of his career in Cape Town, South Africa. After completing specialist training in Internal Medicine and Infectious Diseases, he undertook a PhD in the clinical pharmacology of linezolid for drug-resistant tuberculosis. Sean recently took up a position at St George’s, University of London, as a Reader in Infectious Diseases at the Institute for Infection and Immunity. Sean maintains an adjunct appointment as Associate Professor in the Division of Infectious Diseases and HIV Medicine in the Department of Medicine at the University of Cape Town, where he is a Principal Investigator at the Centre for Infectious Diseases Research in Africa (CIDRI-Africa). He also holds honorary appointments as an Associate Professor at the MRC Centre for Medical Mycology, University of Exeter, and as an International Fellow at the Population Health Research Institute, McMaster University. Sean served as a pharmacologist on the ACTG Tuberculosis Transformative Science Group from 2019 to 2023 and is a member of the NIH-CDC-HIVMA/IDSA Guidelines Committee for Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. The Lancet journal profiled Sean as a ‘rising star in TB-HIV research and medicine’ and has received awards from the International Society for Infectious Diseases (ISID), the InterAcademy Partnership, and the International Union against Tuberculosis and Lung Disease. He is an ISID council member.

Sally Roberts

Dr. Sally Roberts is a Fellow of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Until recently, she was the Clinical Director for the Department of Pathology and Laboratory Medicine (LabPlus). She is the Clinical Lead for Microbiology at Te Whatu Ora (Health New Zealand) Te Toka Tumai Auckland district. She is an honorary senior lecturer at the University of Auckland and an associate investigator for the Maurice Wilkins Centre for Molecular Biodiscovery, one of the seven Centres of Research Excellence in New Zealand. She also works for Te Tāhū Hauora, Health Quality & Safety Commission New Zealand as the National Clinical Lead for the Infection Prevention and Control (IPC) programme supporting the Hand Hygiene New Zealand, Surgical Site Infection Improvement programme and other quality improvement programmes. This role fosters her strong interest in clinical governance and patient safety. Over the last five years, Dr. Roberts has been on the Ministry of Health (MOH), Health Antimicrobial Resistance Coordinating Group, the MOH National COVID-19 Technical Advisory Group, and chaired the IPC TAG. She enjoys teaching and has contributed to the professional development of many of her junior colleagues across New Zealand.

Paul Ananth Tambyah

Paul Ananth Tambyah is the current International Society for Infectious Diseases president. He is a Professor of Medicine at the National University of Singapore and a Senior Consultant Infectious Diseases Physician at the National University Health System. After graduating from the National University of Singapore Faculty of Medicine and completing national service in the Singapore Armed Forces Medical Corps, he trained in Infectious Diseases under Dr. Dennis Maki at the University of Wisconsin. Since returning to Singapore more than 20 years ago, he has served on several national and international committees. He is also past President of the Asia Pacific Society of Clinical Microbiology and Infection. His research interests are in device-associated infections and emerging infectious diseases.

Linda MacKinnon

Linda is the Chief Executive Officer of the ISID. A dedicated and long-standing champion of healthcare equity, infectious disease advocacy, and epidemic intelligence innovations, Ms. MacKinnon leads the Society’s extensive Program Portfolio mission. Ms. MacKinnon believes that early warning detection, management, and education of infectious diseases in a One Health context is necessary to empower those shouldering the heaviest burden of diseases, especially those living in low- and low-middle-income countries. Before joining ISID, Linda spent years leading ongoing information technology support and onsite subject matter expertise to further directives for AIDS relief in various countries, including Eswatini, Kenya, Tanzania, Mozambique, Vietnam, and Ukraine. Linda served as lead Epidemiologist at Atlanta’s US Centers for Disease Control and Prevention (CDC) within the CDC’s National Center for Infectious Diseases. Prior to the CDC, Linda lived and worked in West Africa, working with frontline community workers to improve the lives of those most in need.

Elkin Bermudez

Dr. Bermudez holds an MD degree from the Universidad del Rosario, completed an MSc in Tropical Medicine and Infectious Diseases in Fiocruz, and holds a Ph.D. in Infectious Diseases from UNIFESP, Brazil, where his research project focused on resistance to HIV antiretroviral treatment. He has been working internationally in the global health field for more than 15 years in international organizations such as MSF and FIND in the areas of Epidemiology, Infectious Diseases, Monitoring & Evaluation, and Operational Research, supporting field teams in countries in Africa, Asia, and the Middle East and from headquarters in Europe. Previously, he worked in clinical research and participated in projects on treating neglected diseases in South America. Dr. Bermudez joined ISID in 2022 and collaborated with the team in advancing the management of scientific agenda-related activities and grant coordination.

Aisha Abubakar

Aisha Abubakar (nee Ahmed Umar) [MBBS, MPH Field Epidemiology, PhD Public Health FWACP] is a seasoned epidemiologist and Public Health Physician. She is a Professor/Consultant with the Ahmadu Bello University and the Ahmadu Bello University Teaching Hospital in Zaria, Northwestern Nigeria. Professor Abubakar has a Master's in Public Health in Field Epidemiology from the Ahmadu Bello University Zaria, a Postgraduate Certificate in Health Research from the University of Lancaster, UK, and a Ph.D. in Public Health from the Atlantic International University, USA. She is also a Fellow of the Faculty of Community Health of the West African College of Physicians (FWACP). She has taken a step from academia and is now a Manager of Scientific Programs at the International Society for Infectious Diseases. She is also a ProMED Anglophone Africa moderator for the International Society for Infectious Diseases. Her main interests are Infectious Disease Epidemiology, Infection Prevention and Control, and Public Health Surveillance. She is passionate about Infectious Diseases and Global Health.

Afreenish Amir

Dr. Afreenish Amir (MBBS, M.Phil, Ph.D. (Microbiology), MPH, CHPE, DHM, Ph.D. Public Health Scholar) is a medical microbiologist with over fifteen years of experience in clinical microbiology and infectious diseases. She is working on implementing the Pakistan National Action Plan on One Health Antimicrobial Resistance, Laboratory systems, AMR and AMC Surveillance, Stewardship, and Advocacy. She has been engaged in the Pakistan AMR Surveillance System (PASS), Candida auris fungal diagnostics, Asia Pathogens Genomics Initiative, Tricycle One Health Integrated AMR Surveillance (WHO), Environmental Surveillance of Cholera, LQMS training and National Antimicrobial Stewardship Program. She has 80 publications in national and international journals, and many are underway. She is a Harvard Kennedy School and GCSP Geneva alumna (on Global Health Security), GIBACHT fellow on biosafety and biosecurity (Germany), Lead Auditor ISO 9001:2015 (CQI, IRCA UK), Ex-Chair Emerging Leaders program in Infectious Diseases ISID (USA), Visiting Faculty Rawalpindi Medical University, a member of the WHO Advisory Group on the Bacterial Priority Pathogen List, a member of the Expert Group for WHO Global AMR Research Agenda in human health, Pakistan Biological Safety Association, Federal Region Chapter Head, Board Director for Mehnaz Fatima Foundation Gilgit, and Consultant Clinical Microbiology for American Society of Microbiology (USA).

Adeeba Kamarulzaman

Professor Adeeba Kamarulzaman is the President and Pro Vice-Chancellor of Monash University Malaysia. Prior to this appointment, she was Dean of the Faculty of Medicine, University Malaya, and continues as an Honorary Professor at UM and as Adjunct Associate Professor at Yale University, USA. An infectious diseases physician by training, Professor Kamarulzaman is a passionate advocate for social justice, especially as it pertains to HIV prevention, treatment and care, and drug policies. She serves as the Chairman of the Malaysian AIDS Foundation and is the immediate Past President of the International AIDS Society. She is also the founding Chair of the ROSE Foundation, an organization committed to eliminating cervical cancer in Malaysia and regionally. At the international level, Professor Kamarulzaman has been an advisor to numerous WHO, UNAIDS, and UNODC committees on HIV/AIDS and substance use. She is presently Vice Chair of WHO’s Science Council and is a member of the Global Commission on Drug Policy and the Global Council on Inequalities, HIV and Pandemics. Her achievements have been recognized through several national and international awards, including as a two-time recipient of the prestigious Merdeka Award and recently as Tokoh Akademik Negara. In April 2015, she was honored with a Doctor of Laws (honoris causa) from her alma mater, Monash University, for her role as a health advocate and contributions to medicine.

Sipho Dlamini

Sipho Dlamini, MBChB, FCP(SA), Cert ID(SA)Phys is an Associate Professor at the University of Cape Town and Groote Schuur Hospital, in the Division of Infectious Diseases and HIV Medicine, the Department of Medicine, Cape Town, South Africa.

He is a clinical Infectious Disease specialist with a research interest in HIV and Tuberculosis and the use of vaccines for vaccine preventable diseases in adults living with HIV infection. He has published over 44 peer-reviewed papers and three book chapters.
His clinical and research activities have provided him with an opportunity to be involved in interesting studies. He is actively involved in teaching and mentoring students locally and internationally. He has been an invited speaker to local and international conferences.

He serves as a member in the following committees; the National Immunisation Safety Expert Committee (NISEC) for the National Department of Health South Africa, WHO African Regional Immunization Technical Advisory Group, ESCMID Professional Affairs Subcommittee (PAS).

Professor Lucille Blumberg

Professor Lucille Blumberg is a highly-respected infectious diseases specialist who sits on many national and international expert groups. Her contribution to keeping the public safe from infectious disease has been hailed as the epitome of sustainable groundbreaking research.

Born in Johannesburg, after matriculating at Parktown High School for Girls, she studied medicine at Wits, graduating in 1974. She did her internship at what is now Helen Joseph Hospital and followed this with a distinguished postgraduate academic career. Her specialist qualifications include a Diploma in Child Health, a diploma in Occupational Health and one in Tropical Medicine and Hygiene. She obtained a specialist Master of Medicine degree in Microbiology from Wits in 2003, and became a subspecialist in Infectious Diseases in South Africa in 2010.

Her work experience started at what is now Chris Hani Baragwanath before becoming Principal Medical Officer at what was then Rietfontein, and is now Sizwe Tropical Diseases Hospital. In 2002 she became a Deputy Director at the National Institute for Communicable Diseases. She still holds this position today. She was the founding head of the Institute’s Division of Public Health, Surveillance and Response. Now she consults to this division which includes travel medicine and clinical infectious diseases.

Professor Blumberg is a sought-after expert in viral outbreaks. This is evident from her membership of a large number of national and international committees.

Gonzalo Bearman

Gonzalo Bearman is Chair of the Division of Infectious Diseases, Richard P. Wenzel Professor of Internal Medicine (Tenure) with a focus on clinical infectious diseases, public health and healthcare epidemiology at the Virginia Commonwealth University Health System. He is a graduate of Colgate University (BA), SUNY at Buffalo School of Medicine and Biomedical Sciences (MD) and Columbia University (MPH). He completed a residency in Internal Medicine and was Chief Resident, both at SUNY at Buffalo. He then completed a fellowship in Infectious Diseases and a residency in Preventive Medicine/Public Health, both at Cornell University. Dr. Bearman is Board Certified in Internal Medicine, Infectious Diseases, and General Preventive Medicine and Public Health.

Dr. Arun Balajee

Dr. Arun Balajee is currently the Associate Director for Global Health Sciences in the Division of Viral Diseases. She has a decade of field experience designing and implementing surveillance programs in countries in every region of the world. Arun has led numerous infectious disease outbreak investigations including Ebola, MERS CoV and SARS CoV2. She is leading a team of epidemiologists who implement event-based surveillance and enhance public health intelligence.

Patrick Baffuto

Founded in 2006, Hybrid Healthcare Communications provides exceptional marketing and advertising services that excite, engage and educate medical audiences. Built on a hybrid of the company's strongest assets-a couple of Nerds, Geeks, and Cool Kids-Hybrid doesn't claim success, we demonstrate it. With an unmatched knowledge of science and strategy, the company's brilliant Nerds, the Medical Team, lay the foundation for success. Hybrid's savvy Geeks, the Technology Development Team, bring an innovative edge to each initiative, boasted by few other pharmaceutical communication agencies. And Hybrid's Account Services Team, the Cool Kids tie it all together in an unparalleled, meaningful way. Hybrid's areas of expertise go far beyond marketing and traditional advertising, and include app, software and platform development; conventions; 3D animation, video development; key opinion leader advocacy development; sales training; meeting planning; publications and promotional medical education, to name a few.

Kokou Alinon

Kokou has over 17 years experience as a healthcare professional and over 14 years as Public Health professional with a strong academic knowledge and professional experiences in Public Health Policy and Management, Monitoring and Evaluation, Disease Surveillance
He is from the Republic of Togo in West Africa with a Master’s degrees (DEA and DESS) in Health Psychology.

Before joining Africa CDC, he worked for Togo’s Ministry of Health as the Palliative Care National Program Coordinator, ensuring the development, management, and implementation of palliative care programs. and, the Lead of the Non Communicable Disease Surveillance Division for more than 4 years

Dr. Jaffar Al-Tawfiq

Dr. Jaffar Al-Tawfiq is the Director of Accreditation & Infection Control at Johns Hopkins Aramco Healthcare Dhahran, Eastern Province, Saudi Arabia. He is an Associate Professor Jaffar Al-Tawfiq is a Consultant of Internal Medicine & Infectious Diseases and the Director of Accreditation and Infection Control at JHAH. He is an Adjunct Associate Professor of Internal Medicine and Infectious Diseases.

Dr. Al-Tawfiq has received several accomplishment awards locally and internationally. He is recognized as a world leader in coronaviruses and is a top global expert in infection control. Dr. Al-Tawfiq is a scientist and researcher, and his current interests include hospital epidemiology, healthcare-associated infections, antimicrobial resistance, antibiotic stewardship, and emerging respiratory pathogens including MERS-CoV and COVID-19. He is also renowned as a researcher in mass gatherings.